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ABSTRACT 
Introduction: Paracetamol (acetaminophen) is the first choice pain relieving medicine 
recommended for pregnant women. Recent findings link paracetamol exposure in 
utero with subsequent genital malformation occurrence in children, as well as asthma, 
ADHD (Attention Deficit Hyperactivity Disorder) and other developmental disorders. 
The reported presence of paracetamol in the urine samples from individuals never 
treated with this medicine indicates other sources of exposure. The industrial 
compound aniline, which is metabolized to paracetamol in the human body, is a 
possible source. The present study investigates the transfer and metabolism of 
paracetamol and aniline in the human placenta, using a human ex vivo placental 
perfusion model. 
Materials and methods: The human ex vivo placental perfusion system was used with 
freshly donated placentae from Caesarean sections from women providing informed 
consent. Paracetamol was added to final concentrations of 2.5µg/ml (n=5) and 25 
µg/ml (n=2) in the maternal circulation, resulting in seven successful perfusions with 
paracetamol. Aniline was added to final concentrations of 25µg/ml (n=2) and 50 
µg/ml (n=1), resulting in one successful perfusion with aniline. Samples from the 
maternal and fetal circulation were collected at different time intervals and analysed 
by UHPLC-MS/MS Triple Quadrupole system. Success criteria for a perfusion were 
the leakage from the fetal reservoir less than 3 ml/h and the fetal/maternal (FM) 
ratio greaterthan 0.75 for antipyrine. Identification of aniline, antipyrine, 
paracetamol and its metabolites was carried out on the base of the Multiple Reaction 
Monitoring (MRM) mode.  
Results: Eight cotyledons were successfully perfused (seven with paracetamol and one 
with aniline). Paracetamol was transferred across the placenta via passive diffusion at 
rates comparable with antipyrine. The metabolite of paracetamol sulfate was present 
initially in the maternal circulation and the concentration increased in both circulations 
during perfusion. The metabolite of paracetamol glucuronide was detected, however 
no clear time dependent pattern was found. Aniline was studied in a single successful 
perfusion where transport and metabolism was found. 
Conclusion: Comparative studies of the transport and metabolism of paracetamol 
and aniline are recommended for the hypothesis of paracetamol from aniline sources 
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also contributing to in utero exposures. Our results support 
information initiatives towards pregnant women in minimising 
their paracetamol intake. 
Abbreviations: 
ADHD: Attention Deficit Hyperactivity Disorder; CV: coefficients 
of variation; FM: fetal/maternal; IP30, indicative permeability 
coefficient; LOD: limit of detection; LOQ: limit of quantitation; 
MRM: multiple reaction monitoring; NA4AP: N-acetyl-4-
aminophenol; NAPQUI/NAPQI: N-acetyl-p-benzoquinoneimine; 
pO2: capillary; UHPLC-MS/MS: ultra high performance liquid 
chromatography – tandem mass spectrometer 
INTRODUCTION 
Paracetamol (acetaminophen, NA4AP, APAP, N-acetyl-4-
aminophenol) is one of the most common analgesic and 
antipyretic over-the-counter medicine. It is the first choice of 
medicine recommended to pregnant women in pain. In 
Denmark more than 50% of women take paracetamol at least 
once during a pregnancy [1]. The ubiquitous presence of 
paracetamol in the urine samples from individuals not 
consuming this medicine indicates other sources of exposure 
[2,3]. One of the exposure sources is industrial compound 
aniline, which is metabolized to paracetamol in the human 
body. Aniline is used in the production of rubber, food, 
cosmetic colorants and pesticides. Recent findings, both from 
epidemiological and animal studies, raise the concern that 
paracetamol exposure in utero may be the cause of a range of 
currently ubiquitous medical concerns in children, such as 
compromised reproductive capacity [4,5] asthma [6], ADHD, 
problems with concentration and other neurological 
disorders[7-9]. Coningset al., (2017) and Weigandet al., 
(1984) used the isolated perfused human placenta tissue and 
showed in their articles that paracetamol can freely pass the 
placental barrier [10,11]. After maternal use before delivery, 
paracetamol metabolites can be detected in newborns urine 
and blood [12,13]. 
The main organ responsible for metabolism of paracetamol 
after oral intake is the liver [14]. The major metabolites of 
paracetamol are: paracetamol glucuronide (~40%), 
paracetamol sulfate (~35%) and a reactive metabolite N-
acetyl-p-benzoquinone imine (NAPQI/NAPQUI; ~5%) [2]. It 
has been shown, that paracetamol metabolism varies among 
humans, which may result in decreased capability of producing 
the nonreactive metabolites [15]. The most abundant 
metabolites (~85%) after aniline exposure is free paracetamol 
and its glucuronide and sulfate conjugates [2]. The present 
study investigates the transfer and metabolism of paracetamol 
and aniline in the human placenta. Using term human 
placentae, obtained immediately after Caesarean sections, a 
human ex vivo placental perfusion model was applied. 
MATERIALS AND METHODS 
Recruitment of donors and sampling of placentae 
After obtaining written consent of women delivering by 
Caesarean section, the placentae were handed to our study 
personnel immediately after birth, weighed and infused with 
heparin in physiological saline to prevent coagulation. The 
placenta was transported to the laboratory and cannulations 
and transport studies performed. The recruitment procedure 
has been approved by the Regional Ethics Committee (No H-
1602 1492). 
Perfusion studies 
The placental dual closed circuit perfusion studies have been 
described in detail by Mathiesen et al., (2014) [16]. A 
chorionic artery-vein pair was cannulated. The cotyledon was 
placed in the perfusion chamber. Three cannulae, representing 
maternal arteries, were placed in the intervillous space through 
the basal plate and flow was established with a recycling 
system. The pre-perfusion (60 minutes) ensured intact perfusion 
of the cannulated cotyledon by flow measurements. The test 
compound was added to the maternal circulation and samples 
from maternal and fetal perfusates were taken at consecutive 
intervals. As control compound antipyrine was added 
(2.5mg/ml). The experiment duration was three hours and it 
was kept under physiological conditions. The values of pH, pO2 
and glucose were corrected during perfusion when outside of 
certain values (pH: 7.45-7.55, pO2: maternal circuit value 
range 6.9- 15.4 kPa, pO2fetal< pO2maternal, glucose: 
>3mmol/l).Success criteria for each perfusion were the 
leakage from the fetal reservoir less than 3 ml/h and the 
fetal/maternal ratio greaterthan 0.75 for antipyrine. From five 
perfusions with paracetamol concentration of 2.5 µg/ml, two 
perfusions with paracetamol concentration of 25 µg/ml, two 
perfusions with aniline concentration of 25 µg/ml and one 
perfusion with aniline concentration of 50 µg/ml, eight 
cotyledons were successfully perfused. 
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Chemicals and materials 
Ammonium carbonate (J.T. Baker, USA)  
Formic acid (Fluka, Germany) 
Ammonia solution (25%, Sigma-Aldrich, Germany) 
Ethyl acetate (Honeywell, Riedel-de-Haёn, Germany) 
Water (Honeywell, Riedel-de-Haёn, Germany) 
Methanol (Honeywell, Riedel-de-Haёn, Israel) 
Acetonitrile (Honeywell, Riedel-de-Haёn, Germany) 
N-acetylbenzoquinoneimine (Sigma-Aldrich, Canada) 
Paracetamol sulfate potassium salt (Sigma-Aldrich, India) 
Paracetamol-β-D-glucuronide (Sigma-Aldrich, Germany) 
Aniline (Merck, Germany) 
Paracetamol (Sigma-Aldrich, analytical grade, Germany) 
Antipyrine (Aldrich-Chemie, Steinheim, Germany) 
Diazepam-D5 (Cerilliant, Round Rock) 
Sample preparations 
For the UHPLC-MS/MS analysis samples were prepared by 
liquid-liquid extraction. To 200 μl of sample 10μl of internal 
standard Diazepam-D5 (Cerilliant, Round Rock) and 200 μl of 
ammonium carbonate buffer (pH = 9) was added. Extraction 
was carried out with 1.2 ml of ethyl acetate on reciprocating 
shaker for 20 min at 280 rpm. Samples were centrifuged at 
17968 x g for 10 min, 1 ml of supernatant was transferred 
and evaporated under stream of nitrogen at 40ºC. The dried 
extracts were diluted in 50 µl of methanol and 10 µl of sample 
was used for injection. 
 
 
UHPLC-MS/MS procedure 
Analysis was performed using ultra high performance liquid 
chromatography (1260 Agilent Technologies, Germany). 
Separation was carried out on Poroshell 120 EC-C180 column 
3.0 x 50 mm with a 2.7 µm particle size (Agilent Technologies, 
USA) at 40ºC. As a mobile phase was used high-purity water 
with 0.1% formic acid (A) and acetonitrile (B). The gradient 
program started with 5% of B, follow by linear gradient up to 
90% B in 5 min, and finishing with 90% B constant for 2 min. 
After this 7 min run time, 3 min of post-time followed using the 
initial 5% of B. The follow rate was set constant at 0.5 ml/min. 
Detection was achieved using triple quadrupole (QqQ 6460, 
Agilent Technologies, USA) equipped with an electros pray 
ionization (ESI) Jet Stream source. Source parameters were 
optimized as follows: collision gas temperature 300ºC, collision 
gas flow 10 l/min, nebulizer 40 psi, sheath gas temperature 
400ºC, sheath gas flow 12 l/min. Identification of aniline, 
antipyrine, paracetamol and its metabolites was carried out on 
the base of the multiple reaction monitoring (MRM) mode. The 
assay was linear from 100 ng/ml to 50000 ng/ml for 
antipyrine, from 10 ng/ml to 5000 ng/ml for aniline and 
paracetamol, from 2 ng/ml to 5000 ng/ml for paracetamol 
glucuronide, paracetamol sulfate and NAPQI. All r2 values 
were 0.995 or greater. Limit of detection (LOD) for all 
compounds was 1 ng/ml. Limit of quantitation (LOQ) for 
aniline, antipyrine and paracetamol was 10ng/ml and 2 ng/ml 
for metabolites. All precision values determined by Coefficients 
of Variation (CV) were below 5%. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Fetal/maternal concentration ratios in placental perfusion studies with paracetamol (2.5µg/ml 
and 25 µg/ml) transported from the maternal circulation to the fetal circulation. Antipyrine is the control 
substance (2.5µg/ml) added to all perfusions (mean ±SD). 
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RESULTS 
Our perfusions show both in the high and low concentration of 
paracetamol (2.5 µg/ml and 25 µg/ml respectively), a 
transfer in a rate similar to antipyrine (including the SD) 
reaching equilibrium at 60-100 minutes perfusion (Figure 1). 
The FM ratio is the ratio of concentrations measured in the fetal 
circulation divided by the concentrations measured in the 
maternal circulation. The permeability rate can be determined 
using the indicative permeability coefficient (IP30). It is defined 
as the slope of the FM ratio curve between time 0 and 30 min, 
assuming a linear regression. The transfer rates (IP30 as 
described in Mose et al., (2012) [17]) of paracetamol (0.0186) 
and antipyrine (0.0211) are very similar (and the transfer rate 
of paracetamol is within the SD of antipyrine transfer rate 
(0.0141-0.0281)). No paracetamol was detected in a blank 
perfusion (results not shown). Paracetamol sulfate was detected 
in all perfusions (Figure 2). Increased levels of this metabolite  
 
 
were detected in the perfusions with high concentrations of 
paracetamol. Perfusion with initial paracetamol concentration 
of 25 µg/ml resulted in the final concentration of paracetamol 
sulfate in the fetal reservoir of 115 ng/ml. No difference was 
seen in paracetamol glucuronide, and NAPQI did not show any 
reliable data (data not shown). 
Only one perfusion with aniline (initial concentration 25 µg/ml) 
hadreliable data and transport as well as metabolism was 
demonstrated (data not shown). Aniline was detected in the 
fetal circulation in all of the timepoints, resulting in the aniline 
concentration of 2130ng/ml in the fetal reservoir after 3h of 
perfusion. Paracetamol sulfate and paracetamol glucuronide 
was detected in fetal reservoir during the experiment. At the 
end of experiments duration paracetamol sulfate concentration 
was 1.85 ng/ml and paracetamol glucuronide was 37.51 
ng/ml in the fetal reservoir. More investigation is needed to 
support this preliminary finding.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: The metabolite paracetamol sulfate was found in maternal and 
fetal circulation fluids at low (2.5µg/ml) as well as high concentrations 
(25µg/ml). Increased levels of this metabolite were detected when high 
concentration of paracetamol was used (mean±SD). 
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DISCUSSION 
Our results confirm human placental transport of paracetamol 
and its metabolites at the concentrations within therapeutic 
range. Paracetamol in human blood samples has effective 
antipyretic properties at plasma concentrations of 10-20 mg/l 
[18]. Studies regarding paracetamol metabolism and 
pharmacokinetics in pregnant and non-pregnant women 
showed, that administration of a standard dose (1 g) resulted 
in a serum concentration peaking at 20.8 g/ml (1.37 x 10-4 
M) 48 minutes after intake [19]. The initial study concentration 
was 2.5 g/ml, which is lower than paracetamol therapeutic 
dose. Our studies confirm that paracetamol crosses the 
placenta via passive diffusion. 
The present study shows that the placenta can metabolize both 
paracetamol and aniline to nontoxic paracetamol sulfate. 
Identifying different paracetamol metabolites abundance after 
placental metabolism may suggest a distinctive detoxifying 
process, when compared with the liver. The results from the 
present study are in contrary to Weigandet al., (1984) [10], 
where no paracetamol metabolites were detected in the 
perfusates. The difference in the findings can be explained 
with variation in perfusion settings and more sensitive methods 
for the metabolite detection available, and a longer duration 
of our experiment. Currently the data on placental metabolism 
of paracetamol are sparse, though it recently has been shown 
that paracetamol sulfate and glucuronide cross the placenta 
[11] and that a single oral dose of paracetamol administrated 
to the mother prior caesarean delivery results in paracetamol 
detection in fetal cord blood [13]. More studies related to the 
transport and metabolisms of aniline in comparison with 
paracetamol are recommended for the source identification of 
paracetamol exposures in non- medicated populations. The 
diversity in adverse outcomes related to prenatal exposures to 
paracetamol and preliminary findings from the present study 
supports further efforts to reconsider the safety of paracetamol 
use during pregnancy. 
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